2FIRSTS INTERVIEW WITH SPANISH HEALTH MINISTRY: No Impending Restrictions for Vape Flavors

Regulations by 2FIRSTS
Jan.11.2024
2FIRSTS INTERVIEW WITH SPANISH HEALTH MINISTRY: No Impending Restrictions for Vape Flavors
The Spanish Ministry of Health has stated that it plans to approve the previously unpassed "Comprehensive Anti-Tobacco Plan" in the first half of 2024. Subsequently, the key milestones for implementation will be determined. Additionally, the current flavor restrictions are only applicable to HTPs, with no imminent plans to extend them to e-cigarettes.

Entering 2024, Spain's newly appointed Minister of Health, Mónica García, will face a series of challenges in the field of tobacco control. To understand the latest policy developments in the country, 2FIRSTS conducted an exclusive interview with her. The ministry expressed its plans to approve the Comprehensive Tobacco Control Plan, which had not been passed by the previous government, in the first half of 2024. Subsequently, key timelines for its implementation will be determined. Furthermore, the restrictions on flavors currently only apply to heated tobacco products, with no imminent plans to expand into the e-cigarette domain.

 

The following is a transcript of the exclusive interview:

 

Q: According to our sources, the 2021-2025 Comprehensive Tobacco Control Plan proposed by Spain's former Minister of Health is set to be a focal point next year. Can the Ministry of Health provide an explanation of this government's stance on the plan, as well as the personal contributions made by the current Minister of Health, Mónica García, in refining its details?

 

A: The comprehensive smoking prevention and control plan for 2022-2025 has been extensively researched and coordinated through close collaboration among local governments, scientific societies, and other stakeholders. It is now ready to be submitted for final evaluation and approval by the inter-regional committee. The plan encompasses interdisciplinary measures and actions in various areas, primarily focusing on regulations, healthcare, environmental protection, and coordination. Within these four aspects, a series of specific goals have been formulated, including the prevention of smoking initiation, promoting smoking cessation, reducing environmental exposure and ecological footprints, and facilitating research and monitoring.

 

Q: Has the Ministry of Health implemented a clear implementation plan regarding this plan so far?

 

A: The department's plan is to approve the plan within the first half of 2024, and subsequently determine the key milestones for implementation.

 

Q: It is worth noting that there has been a two-year gap between the proposal and implementation of this plan. Since the passing of the Act 579/2017 in 2017, there has been a legal void for a period of five years. How would you explain this gap in legislation and enforcement?

 

A: In the previous government, the plan was not proposed or approved, so there was no two-year delay between proposal and execution. Regarding the absence of the new law, it is worth mentioning that reform requires the proposal and approval of the plan as a first step. Finally, it is worth mentioning that there has indeed been a change in the regulatory field. Currently, the implementation of the relevant directive on heated tobacco is imminent. Currently, the process has reached its final stage and has obtained the endorsement of the State Council, with only the approval of the State Council remaining as the final step.

 

Q: What is the minister's perspective on e-cigarettes? In the foreseeable future, are e-cigarettes considered as a means to reduce tobacco-related harm or as an alternative tobacco production method in Spain?

 

A: Currently, scientific evidence has yet to confirm the supposed reduction in harm of e-cigarettes. In Spain, all scientific societies and local governments unanimously oppose this viewpoint. Therefore, the agreement reached by the Health Public Committee of the National Health System's Interregional Committee explicitly states: "Therefore, the Health Public Committee of the National Health System's Interregional Committee, with the objective of promoting public health and preventing smoking-related diseases, warns that the use of traditional tobacco products, so-called 'heated tobacco products' (non-combustible), and 'nicotine-releasing devices' (e-cigarettes) all carry health risks. It is therefore advised not to consume any of these products.

 

Q: According to Law No. 579 of 2017, Spain has prohibited the use of menthol and flavored cigarettes. In the future, will this flavor restriction also apply to e-cigarettes?

 

A: Currently, the Royal Decree 579/2017 of 2017 is undergoing review. As mentioned earlier, its scope is limited to heated tobacco products and therefore does not affect e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives